DUAL-ACTING THROMBOXANE RECEPTOR ANTAGONIST SYNTHASE INHIBITORS - HETEROCYCLIC VARIATIONS

被引：7
|
作者：
FAULL, AW
GASKIN, H
HADFIELD, PS
JESSUP, R
RUSSELL, K
WATKINS, WJ
WAYNE, M
机构：
[1] ICI PHARMACEUT PLC,DEPT CHEM 2,MERESIDE,ALDERLEY PK,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND
[2] ICI PHARMACEUT PLC,DEPT BIOSCI 2,MACCLESFIELD SK10 4TG,CHESHIRE,ENGLAND
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1992年 / 2卷 / 10期
关键词：
D O I：
10.1016/S0960-894X(00)80210-3
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The ability of 1,3-dioxanes bearing a variety of aromatic heterocycles at C4 to inhibit thromboxane synthase has been examined. Potent dual-acting thromboxane receptor antagonist/thromboxane synthase inhibitors have been discovered.
引用
收藏
页码：1181 / 1186
页数：6
相关论文
共 50 条
  • [21] Dual-acting histone deacetylase-topoisomerase I inhibitors
    Guerrant, William
    Patil, Vishal
    Canzoneri, Joshua C.
    Yao, Li-Pan
    Hood, Rebecca
    Oyelere, Adegboyega K.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (11) : 3283 - 3287
  • [22] DISCOVERY OF DUAL ACTIVITY MOLECULES WITH THROMBOXANE ANTAGONIST AND THROMBOXANE SYNTHASE INHIBITORY ACTIVITY
    RUSSELL, K
    GASKIN, H
    JESSUP, R
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (09) : 979 - 984
  • [23] SYNTHESIS OF DUAL ACTIVITY MOLECULES WITH THROMBOXANE ANTAGONIST AND THROMBOXANE SYNTHASE INHIBITORY ACTIVITY
    RUSSELL, K
    GASKIN, H
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (09) : 985 - 986
  • [24] Indirect-acting strategy of opioid action instead of direct receptor activation: dual-acting enkephalinase inhibitors (DENKIs)
    Raffa, R. B.
    Pergolizzi, J. V., Jr.
    Taylor, R., Jr.
    Ossipov, M. H.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (04) : 443 - 449
  • [25] Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531
    Dogné, JM
    Rolin, S
    de Leval, X
    Benoit, P
    Neven, P
    Delarge, J
    Kohl, P
    Damas, J
    David, JL
    Masereel, B
    CARDIOVASCULAR DRUG REVIEWS, 2001, 19 (02): : 87 - 96
  • [26] SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF COMBINED THROMBOXANE RECEPTOR ANTAGONIST THROMBOXANE SYNTHASE INHIBITORS - PYRIDINE-CONTAINING AMINO-PROSTANOIDS
    CAMPBELL, IB
    COLLINGTON, EW
    FINCH, H
    HAYES, R
    LUMLEY, P
    MILLS, K
    ROBERTSON, GM
    WHARTON, K
    WATTS, IS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (12) : 695 - 698
  • [27] CONTRASTING EFFECT OF THROMBOXANE SYNTHASE INHIBITORS AND A THROMBOXANE RECEPTOR ANTAGONIST ON THE DEVELOPMENT OF ANGIOTENSIN-II-SALT-INDUCED HYPERTENSION IN RATS
    MISTRY, M
    NASJLETTI, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 253 (01): : 90 - 94
  • [28] A pharmacophore model for sulphonyl-urea (-cyanoguanidine) compounds with dual action, thromboxane receptor antagonists and thromboxane synthase inhibitors
    Michaux, C
    Dogné, JM
    Rolin, S
    Masereel, B
    Wouters, J
    Durant, F
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (7-8) : 703 - 710
  • [29] Search for structurally diverse heterocyclic analogs as dual-acting antimalarial and antileishmanial agents: An overview
    Faheem, Sanchita
    Dey, Sanchita
    Johri, Samridhi
    Abirami, M.
    Kumar, Banoth Karan
    Taramelli, Donatella
    Basilico, Nicoletta
    Balana-Fouce, Rafael
    Sekhar, Kondapalli Venkata Gowri Chandra
    Murugesan, Sankaranarayanan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2022, 4
  • [30] Dual-acting peptide with prolonged GLP-1 receptor agonist and glucagon receptor antagonist activity for the treatment of type 2 diabetes
    Claus, Thomas
    Pan, Clark
    Buxton, Joanne
    Tom, Irene
    Reynolds, Jennifer
    Barucci, Nicole
    Yang, Ling
    Burns, Michael
    Zhu, Jian
    Yung, Stephanie
    Milardo, Lucinda
    Ortiz, Astrid
    Roczniak, Steve
    Livingston, James
    Clairmont, Kevin
    Whelan, James
    DIABETES, 2006, 55 : A325 - A325
12345